Genomes2Drugs: identifies target proteins and lead drugs from proteome data.
BACKGROUND:Genome sequencing and bioinformatics have provided the full hypothetical proteome of many pathogenic organisms. Advances in microarray and mass spectrometry have also yielded large output datasets of possible target proteins/genes. However, the challenge remains to identify new targets fo...
Main Authors: | David Toomey, Heinrich C Hoppe, Marian P Brennan, Kevin B Nolan, Anthony J Chubb |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-07-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2704375?pdf=render |
Similar Items
-
Potential repurposing of four FDA approved compounds with antiplasmodial activity identified through proteome scale computational drug discovery and in vitro assay
by: Bakary N’tji Diallo, et al.
Published: (2021-01-01) -
Target-similarity search using Plasmodium falciparum proteome identifies approved drugs with anti-malarial activity and their possible targets.
by: Reagan M Mogire, et al.
Published: (2017-01-01) -
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes
by: Ilaria Piazza, et al.
Published: (2020-08-01) -
Protein target discovery of drug and its reactive intermediate metabolite by using proteomic strategy
by: Lianghai Hu, et al.
Published: (2012-04-01) -
Using existing drugs as leads for broad spectrum anthelmintics targeting protein kinases.
by: Christina M Taylor, et al.
Published: (2013-02-01)